Recent Updates
Recently added Catalysts

Acetylsalicyclic acid

Phase 3

Drugs, Investigational | Small molecule | Other |Bayer AG|Last Updated: Dec 19, 2018

Target and mechanism

ModalitySmall molecule

Also known as Acetylsalicyclic acid (Fast release Aspirin, BAY1019036), Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedDouble-BlindPLACEBO_CONTROLLED
Total Trials1
Total Enrollment500

FDA Designations

No designations recorded

Clinical trial landscape

Acetylsalicyclic acid · 2 trials · 2 indications

Phase 3 2
NCT01420094Evaluate Onset of Action of a Fast Release AspirinHealthy Subjects
COMPLETED510 Analytics
NCT01122602Evaluate Analgesic Efficacy of Fast Release AspirinDrugs, Investigational
COMPLETED500 Analytics
PHASE3COMPLETED
Evaluate Onset of Action of a Fast Release Aspirin
Healthy SubjectsUnlock trial analytics
PHASE3COMPLETED
Evaluate Analgesic Efficacy of Fast Release Aspirin
Drugs, InvestigationalUnlock trial analytics

Study Endpoints

Primary Endpoints

Time to Meaningful Pain Relief (PR)
0 to 6 hours
Time to First Perceptible Pain Relief (PR)
0 to 6 hours
Time to First Perceptible Pain Relief Confirmed
0 to 6 hours

Secondary Endpoints

Time to First Perceptible Pain Relief
0 to 6 hours
Time to First Perceptible Pain Relief Confirmed
0 to 6 hours
Pain Intensity at 5, 10, 15, 20, 25, 30, 35, 40, 50, and 60 minutes and at 1.5, 2, 3, 4, 5, and 6 hours After Dosing
5, 10, 15, 20, 25, 30, 35, 40, and 50 minutes and 1, 1.5, 2, 3, 4, 5, and 6 hours post-dose
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingTRIPLE
ModelPARALLEL
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Arm 1EXPERIMENTAL -
Arm 2ACTIVE_COMPARATOR -
Arm 3PLACEBO_COMPARATOR -

Interventions

NameTypeDescription
Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)DRUGSingle oral dose of fast release aspirin tablet 1000 mg (2 x 500 mg) and 2 placebo-matching acetaminophen caplets with a full glass of water (240 milliliter \[mL\]) between 1-4 hours post dental surgery.
Acetaminophen (Tylenol extra strength)DRUGSingle oral dose of acetaminophen (Tylenol extra strength) caplet 1000 mg (2 x 500 mg) and 2 placebo matching aspirin tablets with a full glass of water (240 mL) between 1-4 hours post dental surgery.
PlaceboDRUGSingle oral dose of placebo (2 placebo aspirin tablets and 2 placebo acetaminophen caplets) with a full glass of water (240 mL) between 1-4 hours post dental surgery.
Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)DRUGSingle dose of fast acting aspirin 2 x 325 mg = 650 mg total
Acetylsalicyclic acid (Aspirin, BAYE4465)DRUGSingle dose of regular aspirin 2 x 325 mg = 650 mg total
Unlock Study Design Details

Eligibility Criteria

Age Range16 Years to 45 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Healthy, ambulatory, male and female volunteers between 16 to 45 years of age * Scheduled to undergo surgical removal of either two partial bony impactions or one full bony alone or in combination with a partial bony impaction, soft tissue impaction or erupted third molar. Max...

Countries:United States
Unlock Eligibility Criteria